BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22716246)

  • 1. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia.
    Kimura A; Terao M; Kato A; Hanafusa T; Murota H; Katayama I; Miyoshi E
    Exp Dermatol; 2012 Jul; 21(7):515-9. PubMed ID: 22716246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological roles of N-acetylglucosaminyltransferase V(GnT-V) in mice.
    Miyoshi E; Terao M; Kamada Y
    BMB Rep; 2012 Oct; 45(10):554-9. PubMed ID: 23101508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha.
    Koivisto L; Jiang G; Häkkinen L; Chan B; Larjava H
    Exp Cell Res; 2006 Sep; 312(15):2791-805. PubMed ID: 16806170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1.
    Langlois S; Cowan KN; Shao Q; Cowan BJ; Laird DW
    Cancer Res; 2010 May; 70(10):4222-32. PubMed ID: 20406988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma.
    Kato A; Yutani M; Terao M; Kimura A; Itoi S; Murota H; Miyoshi E; Katayama I
    Exp Dermatol; 2015 Aug; 24(8):585-90. PubMed ID: 25876794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HB-EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular ATP and involves both p38 and ERK1/2 signaling pathways.
    Giltaire S; Lambert S; Poumay Y
    J Cell Physiol; 2011 Jun; 226(6):1651-9. PubMed ID: 21413023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing.
    Terao M; Ishikawa A; Nakahara S; Kimura A; Kato A; Moriwaki K; Kamada Y; Murota H; Taniguchi N; Katayama I; Miyoshi E
    J Biol Chem; 2011 Aug; 286(32):28303-11. PubMed ID: 21697088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF-mediated migration signaling activated by N-acetylglucosaminyltransferase-V via receptor protein tyrosine phosphatase kappa.
    Wang C; Yang Y; Yang Z; Liu M; Li Z; Sun L; Mei C; Chen H; Chen L; Wang L; Zha X
    Arch Biochem Biophys; 2009 Jun; 486(1):64-72. PubMed ID: 19236842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors Mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy.
    Varani J; Zeigler M; Dame MK; Kang S; Fisher GJ; Voorhees JJ; Stoll SW; Elder JT
    J Invest Dermatol; 2001 Dec; 117(6):1335-41. PubMed ID: 11886492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells.
    Huang B; Sun L; Cao J; Zhang Y; Wu Q; Zhang J; Ge Y; Fu L; Wang Z
    Oncol Rep; 2013 Jun; 29(6):2392-400. PubMed ID: 23563846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.
    Partridge EA; Le Roy C; Di Guglielmo GM; Pawling J; Cheung P; Granovsky M; Nabi IR; Wrana JL; Dennis JW
    Science; 2004 Oct; 306(5693):120-4. PubMed ID: 15459394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.
    Shirakata Y; Kimura R; Nanba D; Iwamoto R; Tokumaru S; Morimoto C; Yokota K; Nakamura M; Sayama K; Mekada E; Higashiyama S; Hashimoto K
    J Cell Sci; 2005 Jun; 118(Pt 11):2363-70. PubMed ID: 15923649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.
    Xu Q; Qu C; Wang W; Gu J; Du Y; Song L
    Cell Biol Int; 2017 Feb; 41(2):124-133. PubMed ID: 27888538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
    Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
    Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.